Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IR (index of reactivity)-house dust mite sublingual immunotherapy liquid formulation for allergic rhinoconjunctivitis: Systematic review and meta-analysis of randomized and nonrandomized studies.
Di Bona D, Carlucci P, Spataro F, Paoletti G, Cognet-Sicé J, Scurati S, Canonica GW. Di Bona D, et al. J Allergy Clin Immunol Glob. 2024 Jan 9;3(2):100208. doi: 10.1016/j.jacig.2024.100208. eCollection 2024 May. J Allergy Clin Immunol Glob. 2024. PMID: 38328804 Free PMC article.
Editorial: pharmacotherapy and evidence-based medicine section.
Paoletti G, Costanzo G, Del Moro L, Spataro F, Carlucci P, Di Bona D. Paoletti G, et al. Among authors: di bona d. Curr Opin Allergy Clin Immunol. 2023 Aug 1;23(4):307-308. doi: 10.1097/ACI.0000000000000919. Curr Opin Allergy Clin Immunol. 2023. PMID: 37431549 No abstract available.
Latex allergy - from discovery to component-resolved diagnosis.
Loverre T, Casella R, Miniello A, Di Bona D, Nettis E. Loverre T, et al. Among authors: di bona d. Endocr Metab Immune Disord Drug Targets. 2023 Sep 1. doi: 10.2174/1871530323666230901102131. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37680164
An update on nonsteroidal anti-inflammatory drug-induced urticaria.
Miniello A, Casella R, Loverre T, Aloia D, Di Bona D, Nettis E. Miniello A, et al. Among authors: di bona d. Endocr Metab Immune Disord Drug Targets. 2023 Sep 7. doi: 10.2174/1871530323666230907112453. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37691219
GM Allotypes and COVID-19. A Pilot Study Performed on Sicilian Patients.
Ligotti ME, Calabrò A, Accardi G, Aiello A, Caruso C, Colomba C, Di Bona D, Duro G, Namboodiri AM, Tuttolomondo A, Pandey JP, Candore G. Ligotti ME, et al. Among authors: di bona d. Transl Med UniSa. 2022 Dec 27;24(2):26-29. doi: 10.37825/2239-9747.1039. eCollection 2022. Transl Med UniSa. 2022. PMID: 37476201 Free PMC article.
Chronic rhinosinusitis with nasal polyposis and biological agents: the ARIA-ITALY Survey.
Lombardi C, Passalacqua G, Menzella F, Mauritz Canevari RF, Danesi G, Pusateri AM, Carone M, Vancheri C, Di Marco F, Micheletto C, Manzotti G, Di Gioacchino M, Bilò MB, Gelardi M, Senna G, Canonica GW; ARIA Italy Panel. Lombardi C, et al. Eur Ann Allergy Clin Immunol. 2024 Mar 27. doi: 10.23822/EurAnnACI.1764-1489.338. Online ahead of print. Eur Ann Allergy Clin Immunol. 2024. PMID: 38534135 Free article.
Meta-analysis in allergy-Statistical recommendations.
Ordak M, Canonica GW, Paoletti G, Brussino L, Carvalho D, Di Bona D. Ordak M, et al. Among authors: di bona d. Allergy. 2024 Feb 29. doi: 10.1111/all.16091. Online ahead of print. Allergy. 2024. PMID: 38425079 No abstract available.
170 results